MedPath

Pediatric Acute Respiratory Distress Syndrome Asia Study

Completed
Conditions
Mechanical Ventilation
Pediatric Intensive Care Unit
Acute Respiratory Distress Syndrome
Registration Number
NCT04068038
Lead Sponsor
KK Women's and Children's Hospital
Brief Summary

Mortality rates in children with pediatric acute respiratory distress syndrome (PARDS) are higher in Asia compared to other regions. In adults with acute respiratory distress syndrome, the only therapy that improves mortality rates is a lung protective ventilation strategy. The pediatric ventilation recommendations are extrapolated from evidence in adults, including ventilation with low tidal volume, low peak/plateau pressures and high-end expiratory pressure. A recent retrospective study of ventilation practices in Asia showed varying practices with regards to pulmonary and non-pulmonary therapies, including ventilation. This study aims to determine the prevalence and outcomes of PARDS in the Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN). This study will also determine the use of pulmonary (mechanical ventilation, steroids, neuromuscular blockade, surfactant, pulmonary vasodilators, prone positioning) and non-pulmonary (nutrition, sedation, fluid management, transfusion) PARDS therapies. To achieve this aim, a prospective observational study which involves systematic screening of all pediatric intensive care unit (PICU) admissions and collection of pertinent clinical data will be conducted. Recruitment will be consecutive and follow up will continue to intensive care discharge.

Detailed Description

The overall objective of this study is to prospectively determine the epidemiology of children with PARDS and describe its management in Asia. The first specific aim is to determine the prevalence of PARDS among PICU admissions. This will be achieved by establishing a systematic manner of screening patients and including them in this study. The second specific aim is to describe the use of pulmonary and non-pulmonary therapies in PARDS. This study will utilize an established dataset to extract pertinent and analyzable clinical data.The third specific aim is to determine the outcome of patients with PARDS. These outcomes will include functional data, PICU mortality, ventilator duration and length of stay data. This is a two-part study - the first part to establish the baseline prevalence and ventilator management strategies, the second part will include the implementation of an evidence based ventilation protocol as part of routine care. The same screening process, eligibility criteria and data collection will apply throughout the two parts. We aim to obtain data for approximately 2years prior to and 2years subsequent to the implementation of the ventilator protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
738
Inclusion Criteria
  • Satisfies the Pediatric Acute Lung Injury Consensus Conference (PALICC) criteria for PARDS
Exclusion Criteria
  • Premature neonates with a corrected age of less than 33 weeks and perinatal lung disease
  • High flow nasal cannula

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of PARDSThrough study completion

Number of participants diagnosed with PARDS over number of intensive care admissions

Mortalityup to 60 days

Number of PARDS participants who died over number of participants diagnosed with PARDS

Secondary Outcome Measures
NameTimeMethod
Extracorporeal membrane oxygenationup to 28 days

Number of participants who require ECMO

Intensive Care Unit free daysup to 28 days

Number of days alive and discharge from the intensive care unit

Ventilator free daysup to 28 days

Number of days alive and free of mechanical ventilation

Trial Locations

Locations (19)

Guangzhou Women and Children's Medical Center

🇨🇳

Guangzhou, Guangzhou, China

Hyogo Prefectural Kobe Children's Hospital

🇯🇵

Hyōgo, Kobe, Japan

Universiti Kebangsaan Malaysia Medical Centre

🇲🇾

Bandar Tun Razak, Kuala Lumpur, Malaysia

King Chulalongkorn Memorial Hospital

🇹🇭

Bangkok, Thailand

Shengjing hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

Post Graduate Institute of Medical Education and Research

🇮🇳

Chandigarh, India

Children's Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Chongqing Hospital

🇨🇳

Chongqing, Sichuan, China

National University Hospital, Singapore

🇸🇬

Singapore, Singapore

Siriraj Hospital

🇹🇭

Bangkok Noi, Bangkok, Thailand

Sanglah Hospital Denpasar

🇮🇩

Denpasar, Bali, Indonesia

Harapan Kita Children and Women hospital

🇮🇩

Jakarta, Indonesia

University Malaya Medical Centre

🇲🇾

Kuala Lumpur, Malaysia

Aga Khan University Hospital

🇵🇰

Karachi, Pakistan

KK Women's and Children's Hospital

🇸🇬

Singapore, Singapore

Sarawak General Hospital

🇲🇾

Kuching, Sarawak, Malaysia

Ramathibodi hospital

🇹🇭

Bangkok, Thailand

National Hospital of Pediatrics

🇻🇳

Dong Da, Hanoi, Vietnam

Hong Kong Children's Hospital

🇭🇰

Kowloon Bay, Kowloon, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath